Flibanserin is specifically approved for use in premenopausal women diagnosed with HSDD, which is characterized by a lack of sexual desire that causes significant distress or interpersonal difficulties and is not due to a co-existing medical or psychiatric condition, problems within the relationship, or the effects of a medication or other drug substance.
